⏰ Last chance! Join Premium for $20/month before it increases to $49/month.

Actinium Pharmaceuticals, Inc

$1.11
-0.02 (-1.77%)

Market Capitalization:

$34.90M

Live Price

Live Volume

Chart Volume 0
Volume 0
5 sec

Actinium Pharmaceuticals, Market Segments

Overnight

*No Trades in Segment

After Hours

*No Trades in Segment

Regular Trading Hours

*No Trades in Segment

Premarket

*No Trades in Segment

After Hours Yesterday

-0.01(-0.89%)
Open$1.12
Close$1.11
Low$1.11
Low Change-0.01 (-0.89%)
High$1.12
High Change+0.00 (+0.00%)
Range$0.01
Volume18.358K
Dollar Volume$20.38K

Regular Trading Hours Yesterday

-0.01(-0.88%)
Open$1.14
Close$1.13
Low$1.10
Low Change-0.04 (-3.51%)
High$1.20
High Change+0.06 (+5.26%)
Range$0.10
Volume74.714K
Dollar Volume$84.43K

Premarket Yesterday

+0.00(+0.00%)
Open$1.16
Close$1.16
Low$1.16
Low Change0.00 (0.00%)
High$1.16
High Change+0.00 (+0.00%)
Range$0.00
Volume113
Dollar Volume$131.08

Actinium Pharmaceuticals, News

There is no current news for this stock at the moment.

Actinium Pharmaceuticals, Top Trades

We are still processing the top long and short trades for today. Please refresh the page in 10 minutes or sign up for Finsuba Premium for real time trade insights.

Actinium Pharmaceuticals, Moving Averages

5 Day Moving Average (SMA5)$1.17
10 Day Moving Average (SMA10)$1.18
20 Day Moving Average (SMA20)$1.19
50 Day Moving Average (SMA50)$1.04
100 Day Moving Average (SMA100)$1.05
200 Day Moving Average (SMA200)$1.15

Actinium Pharmaceuticals, Statistics

Average Volume (30 Days)137.2K
P/E Ratio (Current)3.17
EPS (Current)$0.36
Dividend Yield0.00%
Free Cash Flow-$23.25M
Cash Ratio3.94
Current Ratio4.08
Quick Ratio4.08
Debt to Equity0.00
Enterprise Value-$624.76K
EV to EBITDA-0.06
EV to Sales-0.02
Price to Book1.18
Price to Cash Flow—
Price to Free Cash Flow—
Price to Sales1.02
Return on Assets0.28%
Return on Equity0.37%

Actinium Pharmaceuticals, Stock Splits

There has been 1 stock split for Actinium Pharmaceuticals, (ATNM). The reverse stock split occured on August 11, 2020 and reduced the outstanding shares at a ratio of 30:1.

DateTypeRatio
Aug 11, 2020Reverse30:1

Actinium Pharmaceuticals, Dividends

There have been no dividends for Actinium Pharmaceuticals, (ATNM).